{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:01:15Z","timestamp":1772164875926,"version":"3.50.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2016,8,8]]},"abstract":"<jats:sec xml:lang=\"en\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Bioavailability of nitric oxide (\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      ) and hydrogen sulfide (H\n                      <jats:sub>2<\/jats:sub>\n                      S) is reduced in heart failure (\n                      <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n                      ). Recent studies suggest cross\u2010talk between\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      and H\n                      <jats:sub>2<\/jats:sub>\n                      S signaling. We previously reported that sodium nitrite (Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      ) ameliorates myocardial ischemia\u2010reperfusion injury and HF. Nuclear factor\u2010erythroid\u20102\u2010related factor 2 (Nrf2) regulates the antioxidant proteins expression and is upregulated by H\n                      <jats:sub>2<\/jats:sub>\n                      S. We examined the Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      effects on endogenous H\n                      <jats:sub>2<\/jats:sub>\n                      S bioavailability and Nrf2 activation in mice subjected to ischemia\u2010induced chronic heart failure (CHF).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Mice underwent 60\u00a0minutes of left coronary artery occlusion and 4\u00a0weeks of reperfusion. Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      (165\u00a0\u03bcg\/kgic) or vehicle was administered at reperfusion and then in drinking water (100\u00a0mg\/L) for 4\u00a0weeks. Left ventricular (LV), ejection fraction (EF),\n                      <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>\n                      end diastolic (\n                      <jats:styled-content style=\"fixed-case\">LVEDD<\/jats:styled-content>\n                      ) and systolic dimensions (\n                      <jats:styled-content style=\"fixed-case\">LVESD<\/jats:styled-content>\n                      ) were determined at baseline and at 4\u00a0weeks of reperfusion. Myocardial tissue was analyzed for oxidative stress and respective gene\/protein\u2010related assays. We found that Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      therapy preserved LVEF, LVEDD and LVSD at 4\u00a0weeks during ischemia\u2010induced HF. Myocardial malondialdehyde and protein carbonyl content were significantly reduced in Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      \u2010treated mice as compared to vehicle, suggesting a reduction in oxidative stress. Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      therapy markedly increased expression of Cu,Zn\u2010superoxide dismutase, catalase, and glutathione peroxidase during 4\u00a0weeks of reperfusion. Furthermore, Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      upregulated the activity of Nrf2, as well as H\n                      <jats:sub>2<\/jats:sub>\n                      S\u2010producing enzymes, and ultimately increased H\n                      <jats:sub>2<\/jats:sub>\n                      S bioavailability in ischemia\u2010induced CHF in mice as compared with vehicle.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Our results demonstrate that Na\n                      <jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content>\n                      <jats:sub>2<\/jats:sub>\n                      therapy significantly improves LV function via increasing H\n                      <jats:sub>2<\/jats:sub>\n                      S bioavailability, Nrf2 activation, and antioxidant defenses.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/jaha.116.003551","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T21:58:44Z","timestamp":1469829524000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Nitrite Therapy Ameliorates Myocardial Dysfunction via H\n                    <sub>2<\/sub>\n                    S and Nuclear Factor\u2010Erythroid 2\u2010Related Factor 2 (Nrf2)\u2010Dependent Signaling in Chronic Heart Failure"],"prefix":"10.1161","volume":"5","author":[{"given":"Erminia","family":"Donnarumma","sequence":"first","affiliation":[{"name":"Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi","family":"Bhushan","sequence":"additional","affiliation":[{"name":"Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kurume University School of Medicine Kurume, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erinn L.","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lefer","sequence":"additional","affiliation":[{"name":"Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazi N.","family":"Islam","sequence":"additional","affiliation":[{"name":"Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2466"},{"key":"e_1_3_3_3_2","first-page":"230","article-title":"Nitric oxide and geriatrics: implications in diagnostics and treatment of the elderly","volume":"8","author":"Torregrossa AC","year":"2011","unstructured":"Torregrossa AC, Aranke M, Bryan NS. Nitric oxide and geriatrics: implications in diagnostics and treatment of the elderly. J Geriatr Cardiol. 2011;8:230\u2013242.","journal-title":"J Geriatr Cardiol"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20664"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.21.11482"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0234600100"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm954"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311908200"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.78.1.58"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-1287-2_14"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000224324.52466.e6"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.11.006"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0837428100"},{"key":"e_1_3_3_14_2","first-page":"105","article-title":"Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion","volume":"3","author":"Lefer DJ","year":"1995","unstructured":"Lefer DJ. Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion. New Horiz. 1995;3:105\u2013112.","journal-title":"New Horiz"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.5.2337"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc3601.094298"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000126497.38281.23"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2009.11.001"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio734"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M806654200"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.06.031"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706579104"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182268b9a"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2009.10.010"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006050450"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22493"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.05.015"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070198"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800700105"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100505"},{"key":"e_1_3_3_31_2","first-page":"4","article-title":"Hydrogen sulfide (h2s)\u2014the third gas of interest for pharmacologists","volume":"59","author":"Lowicka E","year":"2007","unstructured":"Lowicka E, Beltowski J. Hydrogen sulfide (h2s)\u2014the third gas of interest for pharmacologists. Pharmacol Rep. 2007;59:4\u201324.","journal-title":"Pharmacol Rep"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2425"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-010-0510-x"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0211hyp"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.199919"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000855"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4612"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705891104"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.833491"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4645"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.014340"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.778688"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2011.06.001"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.324566"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(96)00493-5"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00163.2015"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001986"},{"key":"e_1_3_3_48_2","first-page":"1","article-title":"Nrf2, a master regulator of detoxification and also antioxidant, anti\u2010inflammatory and other cytoprotective mechanisms, is raised by health promoting factors","volume":"67","author":"Martin L","year":"2015","unstructured":"Martin L, Paul SL. Nrf2, a master regulator of detoxification and also antioxidant, anti\u2010inflammatory and other cytoprotective mechanisms, is raised by health promoting factors. Acta Physiologica Sinica. 2015;67:1\u201318.","journal-title":"Acta Physiologica Sinica"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.4161\/auto.6.4.12244"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2003.12.002"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1321871111"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.05.026"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2945"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.004093"},{"key":"e_1_3_3_55_2","first-page":"199","article-title":"Contribution of hydrogen sulfide and nitric oxide to exercise\u2010induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats","volume":"375","author":"Gu Q","year":"2013","unstructured":"Gu Q, Wang B, Zhang XF, Ma YP, Liu JD, Wang XZ. Contribution of hydrogen sulfide and nitric oxide to exercise\u2010induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats. Mol Cell Biochem. 2013;375:199\u2013206.","journal-title":"Mol Cell Biochem"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2007.08.087"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00040.2008"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00207.2006"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2006.03.021"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2011.00104"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.21.6008"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205835200"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.01.058"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1159\/000129686"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.920991"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300484"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2014.04.006"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.189480"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.05.005"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.108.187427"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-015-0166-x"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.116.003551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:19:38Z","timestamp":1715581178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.116.003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8,8]]}},"alternative-id":["10.1161\/JAHA.116.003551"],"URL":"https:\/\/doi.org\/10.1161\/jaha.116.003551","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726588757.793523343","asserted-by":"object"}]},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]},"assertion":[{"value":"2016-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e003551"}}